Currently, there are 88.52M common shares owned by the public and among those 24.48M shares have been available to trade.
The company’s stock has a 5-day price change of -8.63% and 26.98% over the past three months. CTRI shares are trading 7.98% year to date (YTD), with the 12-month market performance down to -20.96% lower. It has a 12-month low price of $14.45 and touched a high of $26.84 over the same period. CTRI has an average intraday trading volume of 482.87K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.07%, 7.25%, and 9.75% respectively.
Institutional ownership of Centuri Holdings Inc (NYSE: CTRI) shares accounts for 22.82% of the company’s 88.52M shares outstanding.
It has a market capitalization of $1.85B and a beta (3y monthly) value of 1.10. The stock’s trailing 12-month PE ratio is 1985.71, while the earnings-per-share (ttm) stands at $0.01. The company has a PEG of 37.64 and a Quick Ratio of 1.57 with the debt-to-equity ratio at 1.84. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.23% over the week and 3.46% over the month.
Analysts forecast that Centuri Holdings Inc (CTRI) will achieve an EPS of 0.26 for the current quarter, 0.32 for the next quarter and 0.91 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.19 while analysts give the company a high EPS estimate of 0.19. Comparatively, EPS for the current quarter was 0.2 a year ago. Earnings per share for the fiscal year are expected to increase by 102.33%, and 38.99% over the next financial year.
Looking at the support for the CTRI, a number of firms have released research notes about the stock. JP Morgan stated their Underweight rating for the stock in a research note on October 07, 2024, with the firm’s price target at $19-$16. UBS coverage for the Centuri Holdings Inc (CTRI) stock in a research note released on July 30, 2024 offered a Neutral rating with a price target of $17. BofA Securities was of a view on June 27, 2024 that the stock is Underperform, while Wells Fargo gave the stock Overweight rating on May 13, 2024, issuing a price target of $29. UBS on their part issued Buy rating on May 13, 2024.
